Pivotal bioVenture Partners Investment Advisor as of Sept. 30, 2025
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 10 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte (PCVX) | 28.6 | $49M | 1.4M | 36.02 | |
| Oculis Holding Ordinary Shares (OCS) | 23.4 | $40M | 2.3M | 17.58 | |
| Arcutis Biotherapeutics (ARQT) | 23.1 | $40M | 2.1M | 18.85 | |
| Zenas Biopharma (ZBIO) | 10.0 | $17M | 779k | 22.20 | |
| Trevi Therapeutics (TRVI) | 6.6 | $12M | 1.3M | 9.15 | |
| Immunome (IMNM) | 3.4 | $5.9M | 503k | 11.71 | |
| Bioage Labs (BIOA) | 2.2 | $3.8M | 653k | 5.88 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 1.7 | $2.9M | 596k | 4.88 | |
| Rallybio Corp (RLYB) | 0.7 | $1.2M | 2.4M | 0.50 | |
| Bolt Biotherapeutics Com New (BOLT) | 0.3 | $503k | 95k | 5.32 |
